Trial · NCT02628106
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy
NCT02628106, Phase 4, Completed, West China Hospital; results first posted 2016-05-24
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy. Trials, record NCT02628106. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02628106
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy
- NCT number
- NCT02628106
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 21 participants, actual
- Lead sponsor
- West China Hospital
- Conditions
- Diabetic Nephropathy
- Interventions
- Lipo-PGE1
- First posted
- 2015-12-11
- Last updated
- 2016-12-29
- Results first posted
- 2016-05-24
- Limitations and caveats
- the small study population and absence of a placebo group and healthy volunteers.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | the Change of Tissue Content of Deoxyhemoglobin Assessed by BOLD-MRI | baseline and after 14days of lipo-PGE1 intravenously | the R2\* value at the time after 14days of lipo-PGE1 intravenously minus the value at the baseline，R2\* is a measure of the tissue content of deoxyhemoglobin. Which is inversely proportional to oxygen content in tissue |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | the Change of Tissue Content of Deoxyhemoglobin Assessed by BOLD-MRI | baseline and after 14days of lipo-PGE1 intravenously | A random sample, west China hospital, in accord with a standard 21 people,age \> 18 years | 1/ms | MEAN |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| the Change of Tissue Content of Deoxyhemoglobin Assessed by BOLD-MRI | Diabetic Nephropathy,Chronic Kidney Disease | 22.04 | Standard Deviation 6.15 | 1/ms |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Diabetic Nephropathy,Chronic Kidney Disease | 21 | |
| Overall Study | COMPLETED | Diabetic Nephropathy,Chronic Kidney Disease | 21 | |
| Overall Study | NOT COMPLETED | Diabetic Nephropathy,Chronic Kidney Disease | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Diabetic Nephropathy,Chronic Kidney Disease | ||
| Total, other adverse events | Diabetic Nephropathy,Chronic Kidney Disease | 0 | 21 |
| Total, serious adverse events | Diabetic Nephropathy,Chronic Kidney Disease | 0 | 21 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02628106
GET https://conductscience.org/api/trials/v1/NCT02628106/registered